CytoSorbents Updates U.S. FDA Regulatory Status of DrugSorb-ATR
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/13/2026
- Nasdaq falls ahead of earnings, economic data while oil rallies
- Oil prices rise on Saudi Arabia attacks, overshadowing Trump's diesel deal
- Will surging equity supply derail the U.S. bull market? Goldman Sachs weighs in
- Broadcom CEO says many AI investors are gamblers
- "Not buying Chipotle": Starbucks squashes blockbuster acquisition speculation
| Cytosorbents Corporation (NASDAQ: CTSO) | Delayed: 3.59 -0.2 (5.28%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.79 | 52 Week High | $7.48 | |||
| Open | $3.65 | 52 Week Low | $3.11 | |||
| Day High | $3.82 | P/E | N/A | |||
| Day Low | $3.51 | EPS | $-0.03 | |||
| Volume | 8,341 | |||||
